Cargando…

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis

BACKGROUND: Increasing numbers of BReast CAncer (BRCA) 1 or 2 pathogenic variant (PV) carriers, who have an inherited predisposition to breast and ovarian cancer, are being identified. Among these women, data regarding the effects of contraception on cancer risks are unclear and various guidelines p...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Bommel, Majke H D, IntHout, Joanna, Veldmate, Guus, Kets, C Marleen, de Hullu, Joanne A, van Altena, Anne M, Harmsen, Marline G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976973/ https://www.ncbi.nlm.nih.gov/pubmed/36383189 http://dx.doi.org/10.1093/humupd/dmac038

Ejemplares similares

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors
por: van Bommel, Majke H. D., et al.
Publicado: (2022)

TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol
por: Steenbeek, Miranda P, et al.
Publicado: (2023)

Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population‐based cohort study
por: Said, Sherin A., et al.
Publicado: (2021)

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
por: Harmsen, Marline G., et al.
Publicado: (2017)

Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study
por: van Lent, Marlies, et al.
Publicado: (2015)

The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single‐centre study
por: Pouwer, AW, et al.
Publicado: (2018)

The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
por: IntHout, Joanna, et al.
Publicado: (2014)

The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease
por: van der Linden, Michelle, et al.
Publicado: (2017)

A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence
por: Makai, Peter, et al.
Publicado: (2017)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits
por: Schrijver, Lieske H, et al.
Publicado: (2022)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

Meta-Analyses of Animal Studies: An Introduction of a Valuable Instrument to Further Improve Healthcare
por: Hooijmans, Carlijn R., et al.
Publicado: (2014)

Risk factors for pelvic organ prolapse and its recurrence: a systematic review
por: Vergeldt, Tineke F. M., et al.
Publicado: (2015)

Impact of a nutritional supplement (Impryl) on male fertility: study protocol of a multicentre, randomised, double-blind, placebo-controlled clinical trial (SUppleMent Male fERtility, SUMMER trial)
por: Smits, Roos, et al.
Publicado: (2020)

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)

Recommendations for diagnosing STIC: a systematic review and meta-analysis
por: Bogaerts, Joep M. A., et al.
Publicado: (2021)

An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia
por: Yuen, Jeanette, et al.
Publicado: (2020)

Plea for routinely presenting prediction intervals in meta-analysis
por: IntHout, Joanna, et al.
Publicado: (2016)

A tutorial on dynamic risk prediction of a binary outcome based on a longitudinal biomarker
por: Dandis, Rana, et al.
Publicado: (2019)

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
por: Whittemore, A S, et al.
Publicado: (2004)

Contraception and Hormone Replacement Therapy in Healthy Carriers of Germline BRCA1/2 Genes Pathogenic Variants: Results from an Italian Survey
por: Massarotti, Claudia, et al.
Publicado: (2022)

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
por: Hakkaart, Christopher, et al.
Publicado: (2022)

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors
por: Stroot, Iris A.S., et al.
Publicado: (2023)

First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants
por: Gelderblom, Malou E., et al.
Publicado: (2023)

Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
por: Kluivers, Kirsten B., et al.
Publicado: (2023)

COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
por: Zhang, Zewen, et al.
Publicado: (2023)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
por: Kitson, Sarah J., et al.
Publicado: (2020)

Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial
por: Milani, Alfredo L., et al.
Publicado: (2017)

Statistical approaches to identify subgroups in meta-analysis of individual participant data: a simulation study
por: Belias, Michail, et al.
Publicado: (2019)

Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)
por: Rookus, MA, et al.
Publicado: (2005)

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

Intracerebral microdialysis of adenosine and adenosine monophosphate – a systematic review and meta‐regression analysis of baseline concentrations
por: van der Mierden, Stevie, et al.
Publicado: (2018)

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
por: Derks-Smeets, Inge A. P., et al.
Publicado: (2018)

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2
por: Bernstein-Molho, Rinat, et al.
Publicado: (2022)

Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial
por: Schulten, Sascha F M, et al.
Publicado: (2019)

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
por: Barnes, Daniel R., et al.
Publicado: (2020)

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

Tissue Engineering in Animal Models for Urinary Diversion: A Systematic Review
por: Sloff, Marije, et al.
Publicado: (2014)

Predicting personalised absolute treatment effects in individual participant data meta‐analysis: An introduction to splines
por: Belias, Michail, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qrvkv6i49ll0pq5989hfcv17dm